# Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria

> **NCT01361269** · PHASE2 · UNKNOWN · sponsor: **Zentopharm GmbH** · enrollment: 100 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Fosmidomycin and clindamycin

## Key facts

- **NCT ID:** NCT01361269
- **Lead sponsor:** Zentopharm GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-05-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361269, "Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01361269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*